Skip to main content
Top
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | Chronic Kidney Disease | Research

Examining the acceptability and feasibility of the Compassionate Mindful Resilience (CMR) programme in adults living with chronic kidney disease: the COSMIC study findings

Authors: Anna Wilson, Claire Carswell, Clare McKeaveney, Karen Atkinson, Stephanie Burton, Clare McVeigh, Lisa Graham-Wisener, Erika Jääskeläinen, William Johnston, Daniel O’Rourke, Joanne Reid, Soham Rej, Ian Walsh, Helen Noble

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

Individuals with chronic kidney disease experience difficult physical and psychological symptoms, that impact quality of life, and are at increased risk of anxiety and depression. Access to specialist psychological support is limited. This study aimed to support a new service development project, in collaboration with Kidney Care UK, to implement the Compassionate Mindful Resilience (CMR) programme, developed by MindfulnessUK, which provides accessible mindfulness techniques and practices to enhance compassion and resilience, and explore its feasibility for people living with stage 4 or 5 kidney disease and transplant.

Methods

A multi-method feasibility design was utilised. Participants over 18 years, from the UK, with stage 4 or 5 kidney disease or post-transplant, and who were not currently undergoing psychotherapy, were recruited to the four-week CMR programme. Data was collected at baseline, post-intervention and three-months post to measure anxiety, depression, self-compassion, mental wellbeing, resilience, and mindfulness. The acceptability of the intervention for a kidney disease population was explored through qualitative interviews with participants, and the Mindfulness Teacher.

Results

In total, 75 participants were recruited to the study, with 65 completing the CMR programme. The majority were female (66.2%) and post-transplant (63.1%). Analysis of completed outcome measures at baseline and post-intervention timepoints (n = 61), and three-months post intervention (n = 45) revealed significant improvements in participant’s levels of anxiety (p < .001) and depression (p < .001), self-compassion (p = .005), mental wellbeing (p < .001), resilience (p.001), and mindfulness (p < .001).
Thematic analysis of interviews with participants (n = 19) and Mindfulness Teacher (n = 1) generated three themes (and nine-subthemes); experiences of the CMR programme that facilitated subjective benefit, participants lived and shared experiences, and practicalities of programme participation. All participants interviewed reported that they found programme participation to be beneficial.

Conclusion

The findings suggest that the CMR programme has the potential to improve psychological outcomes among people with chronic kidney disease. Future randomized controlled trials are required to further test its effectiveness.
Appendix
Available only for authorised users
Literature
2.
go back to reference Donahue S, Quinn DK, Cukor D, Kimmel PL. Anxiety presentations and treatments in populations with kidney disease. Semin Nephrol. 2021;41(6):516–25.PubMedCrossRef Donahue S, Quinn DK, Cukor D, Kimmel PL. Anxiety presentations and treatments in populations with kidney disease. Semin Nephrol. 2021;41(6):516–25.PubMedCrossRef
3.
go back to reference Tsai Y-C, Chiu Y-W, Hung C-C, Hwang S-J, Tsai J-C, Wang S-L, et al. Association of symptoms of depression with progression of CKD. Am J Kidney Dis. 2012;60(1):54–61.PubMedCrossRef Tsai Y-C, Chiu Y-W, Hung C-C, Hwang S-J, Tsai J-C, Wang S-L, et al. Association of symptoms of depression with progression of CKD. Am J Kidney Dis. 2012;60(1):54–61.PubMedCrossRef
4.
go back to reference Dew MA, Rosenberger EM, Myaskovsky L, Dimartini AF, Devito Dabbs AJ, Posluszny DM, et al. Depression and anxiety as risk factors for morbidity and mortality after organ transplantation. Transplantation. 2015;100(5):988–1003.PubMedPubMedCentralCrossRef Dew MA, Rosenberger EM, Myaskovsky L, Dimartini AF, Devito Dabbs AJ, Posluszny DM, et al. Depression and anxiety as risk factors for morbidity and mortality after organ transplantation. Transplantation. 2015;100(5):988–1003.PubMedPubMedCentralCrossRef
5.
go back to reference Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82–99.PubMedCrossRef Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82–99.PubMedCrossRef
6.
go back to reference Hackett ML, Jardine MJ. We need to talk about depression and dialysis: but what questions should we ask, and does anyone know the answers? Clin J Am Soc Nephrol. 2017;12(2):222–4.PubMedPubMedCentralCrossRef Hackett ML, Jardine MJ. We need to talk about depression and dialysis: but what questions should we ask, and does anyone know the answers? Clin J Am Soc Nephrol. 2017;12(2):222–4.PubMedPubMedCentralCrossRef
7.
go back to reference Seekles ML, Ormandy P, Coyne E. Mapping the UK renal psychosocial workforce: the first comprehensive workforce survey. BMC Nephrol. 2019;20(1):1.CrossRef Seekles ML, Ormandy P, Coyne E. Mapping the UK renal psychosocial workforce: the first comprehensive workforce survey. BMC Nephrol. 2019;20(1):1.CrossRef
8.
go back to reference Ortiz A, Cozzolino M, Fliser D, Fouque D, Goumenos D, Massy ZA, et al. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021;36(1):87–94.CrossRef Ortiz A, Cozzolino M, Fliser D, Fouque D, Goumenos D, Massy ZA, et al. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021;36(1):87–94.CrossRef
9.
go back to reference Antoun J, Brown DJ, Jones DJW, Sangala NC, Lewis RJ, Shepherd AI, et al. Understanding the impact of initial COVID-19 restrictions on physical activity, wellbeing and quality of life in shielding adults with end-stage renal disease in the united kingdom dialysing at home versus in-centre and their experiences with telemedicine. Int J Environ Res Public Health. 2021;18(6):3144.PubMedPubMedCentralCrossRef Antoun J, Brown DJ, Jones DJW, Sangala NC, Lewis RJ, Shepherd AI, et al. Understanding the impact of initial COVID-19 restrictions on physical activity, wellbeing and quality of life in shielding adults with end-stage renal disease in the united kingdom dialysing at home versus in-centre and their experiences with telemedicine. Int J Environ Res Public Health. 2021;18(6):3144.PubMedPubMedCentralCrossRef
10.
go back to reference McKeaveney C, Noble H, Carswell C, Johnston W, Reid J. Psychosocial well-being of patients with kidney failure receiving haemodialysis during a pandemic: a survey. Healthcare. 2021;9(8):1087.PubMedPubMedCentralCrossRef McKeaveney C, Noble H, Carswell C, Johnston W, Reid J. Psychosocial well-being of patients with kidney failure receiving haemodialysis during a pandemic: a survey. Healthcare. 2021;9(8):1087.PubMedPubMedCentralCrossRef
11.
go back to reference Voorend CGN, van Oevelen M, Nieberg M, Meuleman Y, Franssen CFM, Joosten H, et al. Impact of the COVID-19 pandemic on symptoms of anxiety and depression and health-related quality of life in older patients with chronic kidney disease. BMC Geriatr. 2021;21(1):650.PubMedPubMedCentralCrossRef Voorend CGN, van Oevelen M, Nieberg M, Meuleman Y, Franssen CFM, Joosten H, et al. Impact of the COVID-19 pandemic on symptoms of anxiety and depression and health-related quality of life in older patients with chronic kidney disease. BMC Geriatr. 2021;21(1):650.PubMedPubMedCentralCrossRef
13.
go back to reference Gu J, Strauss C, Bond R, Cavanagh K. How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies. Clin Psychol Rev. 2015;37:1–12.PubMedCrossRef Gu J, Strauss C, Bond R, Cavanagh K. How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies. Clin Psychol Rev. 2015;37:1–12.PubMedCrossRef
14.
go back to reference Kabat-Zinn J. Mindfulness-Based Stress Reduction (MBSR). Constructivism Human Sci. 2003;8(2):73–83. Kabat-Zinn J. Mindfulness-Based Stress Reduction (MBSR). Constructivism Human Sci. 2003;8(2):73–83.
15.
go back to reference Merkes M. Mindfulness-based stress reduction for people with chronic diseases. Aust J Prim Health. 2010;16(3):200–10.PubMedCrossRef Merkes M. Mindfulness-based stress reduction for people with chronic diseases. Aust J Prim Health. 2010;16(3):200–10.PubMedCrossRef
16.
go back to reference Kilic A, Hudson J, McCracken LM, Ruparelia R, Fawson S, Hughes LD. A systematic review of the effectiveness of self-compassion-related interventions for individuals with chronic physical health conditions. Behav Ther. 2021;52(3):607–25.PubMedCrossRef Kilic A, Hudson J, McCracken LM, Ruparelia R, Fawson S, Hughes LD. A systematic review of the effectiveness of self-compassion-related interventions for individuals with chronic physical health conditions. Behav Ther. 2021;52(3):607–25.PubMedCrossRef
17.
go back to reference Razzera BN, Adamoli AN, Ranheiri MF, Oliveira MDS, Feoli AMP. Impacts of mindfulness-based interventions in people undergoing hemodialysis: a systematic review. Brazilian Journal of Nephrology. 2022;44(1):84–96.PubMedCrossRef Razzera BN, Adamoli AN, Ranheiri MF, Oliveira MDS, Feoli AMP. Impacts of mindfulness-based interventions in people undergoing hemodialysis: a systematic review. Brazilian Journal of Nephrology. 2022;44(1):84–96.PubMedCrossRef
21.
go back to reference Atkinson K. Compassionate Mindful Inquiry in Therapeutic Practice. London, UK: Singing Dragon; 2020. Atkinson K. Compassionate Mindful Inquiry in Therapeutic Practice. London, UK: Singing Dragon; 2020.
22.
go back to reference Wilson A, McKeaveney C, Carswell C, Atkinson K, Burton S, McVeigh C, et al. Examining the acceptability and feasibility of the Compassionate Mindful Resilience (CMR) programme in adult patients with chronic kidney disease: the COSMIC study protocol. Healthcare. 2022;10(8):1387.PubMedPubMedCentralCrossRef Wilson A, McKeaveney C, Carswell C, Atkinson K, Burton S, McVeigh C, et al. Examining the acceptability and feasibility of the Compassionate Mindful Resilience (CMR) programme in adult patients with chronic kidney disease: the COSMIC study protocol. Healthcare. 2022;10(8):1387.PubMedPubMedCentralCrossRef
23.
go back to reference Kounali D, Button KS, Lewis G, Gilbody S, Kessler D, Araya R, et al. How much change is enough? Evidence from a longitudinal study on depression in UK primary care. Psychol Med. 2022;52(10):1875–82.PubMedCrossRef Kounali D, Button KS, Lewis G, Gilbody S, Kessler D, Araya R, et al. How much change is enough? Evidence from a longitudinal study on depression in UK primary care. Psychol Med. 2022;52(10):1875–82.PubMedCrossRef
24.
go back to reference Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder. Arch Intern Med. 2006;166(10):1092.PubMedCrossRef Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder. Arch Intern Med. 2006;166(10):1092.PubMedCrossRef
25.
go back to reference Stoop CH, Nefs G, Pommer AM, Pop VJ, Pouwer F. Effectiveness of a stepped care intervention for anxiety and depression in people with diabetes, asthma or COPD in primary care: A randomized controlled trial. J Affect Disord. 2015;184:269–76.PubMedCrossRef Stoop CH, Nefs G, Pommer AM, Pop VJ, Pouwer F. Effectiveness of a stepped care intervention for anxiety and depression in people with diabetes, asthma or COPD in primary care: A randomized controlled trial. J Affect Disord. 2015;184:269–76.PubMedCrossRef
26.
go back to reference Meyerowitz-Katz G, Ravi S, Arnolda L, Feng X, Maberly G, Astell-Burt T. Rates of attrition and dropout in app-based interventions for chronic disease: systematic review and meta-analysis. J Med Internet Res. 2020;22(9):e20283.PubMedPubMedCentralCrossRef Meyerowitz-Katz G, Ravi S, Arnolda L, Feng X, Maberly G, Astell-Burt T. Rates of attrition and dropout in app-based interventions for chronic disease: systematic review and meta-analysis. J Med Internet Res. 2020;22(9):e20283.PubMedPubMedCentralCrossRef
27.
go back to reference Silver Lake. Qualtrics. Provo, Utah, USA2020. Silver Lake. Qualtrics. Provo, Utah, USA2020.
29.
go back to reference Raes F, Pommier E, Neff KD, Van Gucht D. Construction and factorial validation of a short form of the Self-Compassion Scale. Clin Psychol Psychother. 2011;18(3):250–5.PubMedCrossRef Raes F, Pommier E, Neff KD, Van Gucht D. Construction and factorial validation of a short form of the Self-Compassion Scale. Clin Psychol Psychother. 2011;18(3):250–5.PubMedCrossRef
30.
go back to reference Baer RA, Smith GT, Lykins E, Button D, Krietemeyer J, Sauer S, et al. Construct validity of the five facet mindfulness questionnaire in meditating and nonmeditating samples. Assessment. 2008;15(3):329–42.PubMedCrossRef Baer RA, Smith GT, Lykins E, Button D, Krietemeyer J, Sauer S, et al. Construct validity of the five facet mindfulness questionnaire in meditating and nonmeditating samples. Assessment. 2008;15(3):329–42.PubMedCrossRef
31.
go back to reference Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, et al. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007;5(1):63.PubMedPubMedCentralCrossRef Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, et al. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007;5(1):63.PubMedPubMedCentralCrossRef
32.
go back to reference Perry JL, Clough PJ, Crust L, Earle K, Nicholls AR. Factorial validity of the mental toughness questionnaire-48. Personality Individ Differ. 2013;54(5):587–92.CrossRef Perry JL, Clough PJ, Crust L, Earle K, Nicholls AR. Factorial validity of the mental toughness questionnaire-48. Personality Individ Differ. 2013;54(5):587–92.CrossRef
33.
go back to reference IBM. SPSS Statistics for Windows. Armonk, NY: IBM Corp; 2021. IBM. SPSS Statistics for Windows. Armonk, NY: IBM Corp; 2021.
34.
go back to reference Polkinghorne DE. Language and meaning: Data collection in qualitative research. J Couns Psychol. 2005;52(2):137–45.CrossRef Polkinghorne DE. Language and meaning: Data collection in qualitative research. J Couns Psychol. 2005;52(2):137–45.CrossRef
35.
go back to reference Guest G, Bunce A, Johnson L. How many interviews are enough?: an experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.CrossRef Guest G, Bunce A, Johnson L. How many interviews are enough?: an experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.CrossRef
36.
go back to reference Forman J, Heisler M, Damschroder LJ, Kaselitz E, Kerr EA. Development and application of the RE-AIM QuEST mixed methods framework for program evaluation. Prev Med Rep. 2017;6:322–8.PubMedPubMedCentralCrossRef Forman J, Heisler M, Damschroder LJ, Kaselitz E, Kerr EA. Development and application of the RE-AIM QuEST mixed methods framework for program evaluation. Prev Med Rep. 2017;6:322–8.PubMedPubMedCentralCrossRef
37.
go back to reference Archibald MM, Ambagtsheer RC, Casey MG, Lawless M. Using zoom videoconferencing for qualitative data collection: perceptions and experiences of researchers and participants. Int J Qual Methods. 2019;18:1609406919874596.CrossRef Archibald MM, Ambagtsheer RC, Casey MG, Lawless M. Using zoom videoconferencing for qualitative data collection: perceptions and experiences of researchers and participants. Int J Qual Methods. 2019;18:1609406919874596.CrossRef
38.
go back to reference Lumivero. NVivo, Version 12. QSR International Pty Ltd; 2018. Lumivero. NVivo, Version 12. QSR International Pty Ltd; 2018.
39.
go back to reference Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef
40.
go back to reference Wilson A, McKeaveney C, Carswell C, Atkinson K, Burton S, McVeigh C, et al. Experiences of people with kidney disease following the implementation of the compassionate mindful resilience programme: qualitative findings from the COSMIC study. Healthcare. 2023;11(22):2926.PubMedPubMedCentralCrossRef Wilson A, McKeaveney C, Carswell C, Atkinson K, Burton S, McVeigh C, et al. Experiences of people with kidney disease following the implementation of the compassionate mindful resilience programme: qualitative findings from the COSMIC study. Healthcare. 2023;11(22):2926.PubMedPubMedCentralCrossRef
41.
go back to reference Greenwood SA, Young HML, Briggs J, Castle EM, Walklin C, Haggis L, et al. Evaluating the effect of a digital health intervention to enhance physical activity in people with chronic kidney disease (Kidney BEAM): a multicentre, randomised controlled trial in the UK. The Lancet Digital Health. 2023. Greenwood SA, Young HML, Briggs J, Castle EM, Walklin C, Haggis L, et al. Evaluating the effect of a digital health intervention to enhance physical activity in people with chronic kidney disease (Kidney BEAM): a multicentre, randomised controlled trial in the UK. The Lancet Digital Health. 2023.
42.
go back to reference Seekles MK, Coyne, E. Ormandy, P. Wells, L. Bevin A. & Danbury-Lee, A. The UK renal psychosocial workforce - a mapping exercise. British Renal Society & Kidney Care UK workforce report, University of Salford.; 2018. Seekles MK, Coyne, E. Ormandy, P. Wells, L. Bevin A. & Danbury-Lee, A. The UK renal psychosocial workforce - a mapping exercise. British Renal Society & Kidney Care UK workforce report, University of Salford.; 2018.
43.
go back to reference Thomas Z, Novak M, Platas SGT, Gautier M, Holgin AP, Fox R, et al. Brief mindfulness meditation for depression and anxiety symptoms in patients undergoing hemodialysis: a pilot feasibility study. Clin J Am Soc Nephrol. 2017;12(12):2008–15.PubMedPubMedCentralCrossRef Thomas Z, Novak M, Platas SGT, Gautier M, Holgin AP, Fox R, et al. Brief mindfulness meditation for depression and anxiety symptoms in patients undergoing hemodialysis: a pilot feasibility study. Clin J Am Soc Nephrol. 2017;12(12):2008–15.PubMedPubMedCentralCrossRef
44.
go back to reference Carver JA, Cheung KL. Feasibility and acceptability of a yogic breathing/mindfulness meditation e-intervention on symptoms and COVID-19-associated anxiety in patients receiving dialysis. J Palliat Med. 2021;24(8):1124–5.PubMedPubMedCentralCrossRef Carver JA, Cheung KL. Feasibility and acceptability of a yogic breathing/mindfulness meditation e-intervention on symptoms and COVID-19-associated anxiety in patients receiving dialysis. J Palliat Med. 2021;24(8):1124–5.PubMedPubMedCentralCrossRef
45.
go back to reference Hernandez R, Burrows B, Wilund K, Cohn M, Xu S, Moskowitz JT. Feasibility of an Internet-based positive psychological intervention for hemodialysis patients with symptoms of depression. Soc Work Health Care. 2018;57(10):864–79.PubMedPubMedCentralCrossRef Hernandez R, Burrows B, Wilund K, Cohn M, Xu S, Moskowitz JT. Feasibility of an Internet-based positive psychological intervention for hemodialysis patients with symptoms of depression. Soc Work Health Care. 2018;57(10):864–79.PubMedPubMedCentralCrossRef
46.
go back to reference Natale P, Gutman T, Howell M, Dansie K, Hawley CM, Cho Y, et al. Recruitment and retention in clinical trials in chronic kidney disease: report from national workshops with patients, caregivers and health professionals. Nephrol Dial Transplant. 2020;35(5):755–64.PubMedCrossRef Natale P, Gutman T, Howell M, Dansie K, Hawley CM, Cho Y, et al. Recruitment and retention in clinical trials in chronic kidney disease: report from national workshops with patients, caregivers and health professionals. Nephrol Dial Transplant. 2020;35(5):755–64.PubMedCrossRef
47.
go back to reference Gillies K, Kearney A, Keenan C, Treweek S, Hudson J, Brueton VC, et al. Strategies to improve retention in randomised trials. Cochrane Database Syst Rev. 2021;2021(4):MR000013. Gillies K, Kearney A, Keenan C, Treweek S, Hudson J, Brueton VC, et al. Strategies to improve retention in randomised trials. Cochrane Database Syst Rev. 2021;2021(4):MR000013.
48.
go back to reference Tulloh RMR, Garratt V, Tagney J, Turner-Cobb J, Marques E, Greenwood R, et al. A pilot randomised controlled trial investigating a mindfulness-based stress reduction (MBSR) intervention in individuals with pulmonary arterial hypertension (PAH): the PATHWAYS study. Pilot Feasib Stud. 2018;4(1):1–1. Tulloh RMR, Garratt V, Tagney J, Turner-Cobb J, Marques E, Greenwood R, et al. A pilot randomised controlled trial investigating a mindfulness-based stress reduction (MBSR) intervention in individuals with pulmonary arterial hypertension (PAH): the PATHWAYS study. Pilot Feasib Stud. 2018;4(1):1–1.
49.
go back to reference Nassim M, Park H, Dikaios E, Potes A, Elbaz S, Mc Veigh C, et al. Brief mindfulness intervention vs. health enhancement program for patients undergoing dialysis: a randomized controlled trial. Healthcare (Basel). 2021;9(6):659.PubMedCrossRef Nassim M, Park H, Dikaios E, Potes A, Elbaz S, Mc Veigh C, et al. Brief mindfulness intervention vs. health enhancement program for patients undergoing dialysis: a randomized controlled trial. Healthcare (Basel). 2021;9(6):659.PubMedCrossRef
50.
go back to reference Alhawatmeh H, Alshammari S, Rababah JA. Effects of mindfulness meditation on trait mindfulness, perceived stress, emotion regulation, and quality of life in hemodialysis patients: a randomized controlled trial. Int J Nurs Sci. 2022;9(2):139–46.PubMedPubMedCentral Alhawatmeh H, Alshammari S, Rababah JA. Effects of mindfulness meditation on trait mindfulness, perceived stress, emotion regulation, and quality of life in hemodialysis patients: a randomized controlled trial. Int J Nurs Sci. 2022;9(2):139–46.PubMedPubMedCentral
51.
go back to reference Assarian F. Efficacy of mindfulness-based stress reduction in hemodialysis patients with anxiety and depression: a randomized, double-blind, parallel-group trial. Electron Physician. 2021;11(1):7370–7. Assarian F. Efficacy of mindfulness-based stress reduction in hemodialysis patients with anxiety and depression: a randomized, double-blind, parallel-group trial. Electron Physician. 2021;11(1):7370–7.
52.
go back to reference Bennett PN, Ngo T, Kalife C, Schiller B. Improving wellbeing in patients undergoing dialysis: can meditation help? Semin Dial. 2018;31(1):59–64.PubMedCrossRef Bennett PN, Ngo T, Kalife C, Schiller B. Improving wellbeing in patients undergoing dialysis: can meditation help? Semin Dial. 2018;31(1):59–64.PubMedCrossRef
53.
go back to reference Gross CR, Reilly-Spong M, Park T, Zhao R, Gurvich OV, Ibrahim HN. Telephone-adapted Mindfulness-based Stress Reduction (tMBSR) for patients awaiting kidney transplantation. Contemp Clin Trials. 2017;57:37–43.PubMedPubMedCentralCrossRef Gross CR, Reilly-Spong M, Park T, Zhao R, Gurvich OV, Ibrahim HN. Telephone-adapted Mindfulness-based Stress Reduction (tMBSR) for patients awaiting kidney transplantation. Contemp Clin Trials. 2017;57:37–43.PubMedPubMedCentralCrossRef
54.
go back to reference Norris KC, Agodoa LY. Unraveling the racial disparities associated with kidney disease. Kidney Int. 2005;68(3):914–24.PubMedCrossRef Norris KC, Agodoa LY. Unraveling the racial disparities associated with kidney disease. Kidney Int. 2005;68(3):914–24.PubMedCrossRef
55.
go back to reference Chin G, Anyanso V, Greeson J. Addressing diversity in mindfulness research on health: a narrative review using the addressing framework. Cooper Rowan Med J. 2019;1(1):2.PubMedPubMedCentralCrossRef Chin G, Anyanso V, Greeson J. Addressing diversity in mindfulness research on health: a narrative review using the addressing framework. Cooper Rowan Med J. 2019;1(1):2.PubMedPubMedCentralCrossRef
56.
go back to reference Poole L, Ramasawmy M, Banerjee A. Digital first during the COVID-19 pandemic: does ethnicity matter? Lancet Public Health. 2021;6(9):e628–30.PubMedCrossRef Poole L, Ramasawmy M, Banerjee A. Digital first during the COVID-19 pandemic: does ethnicity matter? Lancet Public Health. 2021;6(9):e628–30.PubMedCrossRef
Metadata
Title
Examining the acceptability and feasibility of the Compassionate Mindful Resilience (CMR) programme in adults living with chronic kidney disease: the COSMIC study findings
Authors
Anna Wilson
Claire Carswell
Clare McKeaveney
Karen Atkinson
Stephanie Burton
Clare McVeigh
Lisa Graham-Wisener
Erika Jääskeläinen
William Johnston
Daniel O’Rourke
Joanne Reid
Soham Rej
Ian Walsh
Helen Noble
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03473-6

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.